0001209191-23-018225.txt : 20230313
0001209191-23-018225.hdr.sgml : 20230313
20230313171058
ACCESSION NUMBER: 0001209191-23-018225
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230303
FILED AS OF DATE: 20230313
DATE AS OF CHANGE: 20230313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Narido Richard Clavano
CENTRAL INDEX KEY: 0001956050
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39976
FILM NUMBER: 23728169
MAIL ADDRESS:
STREET 1: 1412 62ND STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lucira Health, Inc.
CENTRAL INDEX KEY: 0001652724
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 272491037
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1315 63RD STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (814) 574-1546
MAIL ADDRESS:
STREET 1: 1315 63RD STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: DiAssess Inc.
DATE OF NAME CHANGE: 20150908
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-03
0
0001652724
Lucira Health, Inc.
LHDX
0001956050
Narido Richard Clavano
1412 62ND ST
EMERYVILLE
CA
94608
0
1
0
0
Chief Financial Officer
Common Stock
2023-03-03
4
S
0
10674
1.14
D
96619
D
Common Stock
2023-03-03
4
S
0
9675
1.07
D
86944
D
Common Stock
2023-03-03
4
S
0
4742
1.00
D
82202
D
Common Stock
2023-03-06
4
S
0
1910
0.57
D
80292
D
Common Stock
2023-03-07
4
S
0
2382
0.45
D
77910
D
/s/ Richard Narido
2023-03-13